Cedar Brook Financial Partners, LLC Amgen Inc Transaction History

Cedar Brook Financial Partners, LLC

$698 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $151,104 - $182,402	562 Added 77.73%	1,285 $365,000
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $5,881 - $6,634	-23 Reduced 3.08%	723 $208,000
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $163,112 - $202,509	746 New	746 $200,000
Q1 2023 Apr 04, 2023	SELL	$225.79 - $275.2 $26,417 - $32,198	-117 Reduced 11.47%	903 $218,000
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $18,093 - $22,989	79 Added 8.4%	1,020 $267,000
Q3 2022 Jan 03, 2023	BUY	$224.46 - $253.15 $3,815 - $4,303	17 Added 1.84%	941 $212,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $7,613 - $8,472	-33 Reduced 3.45%	924 $225,000
Q1 2022 Apr 06, 2022	SELL	$219.27 - $242.57 $10,744 - $11,885	-49 Reduced 4.87%	957 $231,000
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $12,927 - $14,794	65 Added 6.91%	1,006 $226,000
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $28,656 - $33,574	-135 Reduced 12.55%	941 $200,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $20,555 - $22,804	88 Added 8.91%	1,076 $262,000
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $33,064 - $38,531	-149 Reduced 13.1%	988 $246,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $23,369 - $27,828	-108 Reduced 8.67%	1,137 $261,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $234 - $260	1 Added 0.08%	1,245 $316,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $41,737 - $51,218	211 Added 20.43%	1,244 $293,000
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $15,125 - $20,061	-83 Reduced 7.44%	1,033 $209,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $10,406 - $13,376	-55 Reduced 4.7%	1,116 $269,000
Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $16,192 - $19,401	-93 Reduced 7.36%	1,171 $227,000
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $15,669 - $18,368	-94 Reduced 6.92%	1,264 $233,000
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $245,621 - $276,869	1,358 New	1,358 $258,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account